Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2013-04-02
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Exercise on Individuals With Parkinson's Disease
NCT00591344
Effects of Physical Activity on the Brain in Parkinson's Disease (PD)
NCT01741584
The Effects of Exercise in Parkinson's Disease
NCT01835652
Exercise Study For People With Parkinson's Disease
NCT00387218
Exercise to Improve Sleep in Parkinson's Disease
NCT05644327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotheses: The investigators anticipate to observe an altered involvement of motor cortex during steady pedaling in individuals suffering from PD. In healthy control subjects it is anticipated that changes in cognition will be observable.
Justification: Hindered movement initiation and continuing locomotion is a common syndrome in PD with profound impact on the patient's mobility and quality of life. So far, the underlying pathophysiology is not completely understood. Since the observation that cortical activity contributes to the muscle activity during locomotion-like tasks underpins the importance of corticospinal function in humans, it is of importance to examine whether this cortical involvement is altered and displays abnormalities in patients with PD. Thus, the approach of corticomuscular coupling during a locomotion-like task would allow for better understanding of the pathophysiology of PD, a prerequisite to develop therapies. Findings of this study will lay the foundation for future long-term studies.
Additionally, by examining the oscillatory EEG patterns during the exercise intervention, the investigator will be able to read out the dose response curve in real time, which will provide information on the optimum intensity and duration of exercise. Findings will help to design future studies and to develop efficient exercise therapy interventions for people with PD.
People living with PD often suffer from cognitive decline, depression, and fatigue. By assessing cognitive function before and after the exercise intervention, there will be laid a foundation for future studies investigating the effect of exercise on cognition. The collected pilot data will be relevant to learn more about the effects of exercise on mood and fatigue as well as concomitant obstacles and facilitators during exercise interventions in patients with PD.
Objectives: The primary objective of this study is to investigate if activity that arises in the motor cortex and contributes to the muscle activity during moderate pedaling is altered in patients with PD compared to healthy gender- and age-matched controls. Thus, to better understand the role of the motor cortex and its contribution in simple automated repetitive tasks in patients with PD there will be analysis of the coherence of the coupling between EEG and EMG from active leg muscles during cycling on a stationary bicycle both in subjects with PD and age and gender matched healthy controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
Subjects with Parkinson's disease
cycling exercise
5 x 3 minute bouts of cycling exercise separated by 3 minute rest periods
Control
Subjects without Parkinson's disease
cycling exercise
5 x 3 minute bouts of cycling exercise separated by 3 minute rest periods
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cycling exercise
5 x 3 minute bouts of cycling exercise separated by 3 minute rest periods
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hoehn and Yahr stage I-III
* Exercise on a regular basis (at least 100 minutes of aerobic exercise per week)
* Montreal Cognitive Assessment score \>/= 24
* Able to communicate with study personnel
* Able to be informed of the nature of the study and willing to give written consent form
Exclusion Criteria
* Significant cardiovascular disease
* Previous stroke
* Not exercising on a regular basis
* Functional disabling dyskinesia
* Functional disabling dystonia
* Smoker
* Significant neurological or psychiatric illness other than PD
* Dementia
* Severe depression
* Significant musculoskeletal disorder (e.g. arthritis)
* Significant metabolic disorder (e.g. diabetes)
* Brain surgery in the past
* Currently taking beta blocker medication
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pacific Parkinson's Research Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
A. Jon Stoessl
Clinical Director of PET
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silke Cresswell, MD
Role: PRINCIPAL_INVESTIGATOR
Pacific Parkinson's Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Parkinson's Research Centre
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H13-00084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.